# CSL Behring plans €185M expansion in Marburg, Germany

CSL Behring announced a €185 million expansion of its facility in Marburg, Germany, to increase production capacity for hereditary angioedema treatments, expected to be completed in 2023, creating 50 jobs.

- Type: Expansion
- Announced: 2019-09-12
- Where: Marburg, Germany
- Value: $203.0M (185.0M EUR)
- Jobs: 50
- Starts operating: 2023
- Status: announced
- Products: treatments for hereditary angioedema
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [CSL Behring](https://endata.com/companies/28726.md)

## Sources

- [csl.com](https://www.csl.com/we-are-csl/vita-original-stories/2019/marburg-site-expansion), 2019-09-12: "CSL Behring has announced plans for a 185 million euro ($203 million) expansion in Marburg, Germany, where the global biotech already has its largest research and production facility."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.